Although there are challenges for clinical and infectious disease pharmacists when trying to apply this concept, here are some considerations and strategies to employ stewardship in this setting.
Kerry LaPlante, PharmD, FCCP, FIDSA, FIDP
Advertisement
LaPlante is the department chairperson and a tenured professor of Pharmacy at the University of Rhode Island as well as the founding director of the Rhode Island Infectious Diseases Antibiotic Research Program at the Providence Veterans Affairs Medical Center.
Articles by Kerry LaPlante, PharmD, FCCP, FIDSA, FIDP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Oral Carbapenem Tebipenem HBr Demonstrates Non-Inferiority to IV Therapy in Phase III PIVOT-PO Trial
2
Introducing Cefiderocol Earlier in Difficult-to-Treat-Infections
3
New Data Highlight Adult Pneumococcal Serotypes with Greater Antibiotic Resistance and Disease Burden Covered by Merck’s Vaccine
4
Lori Handy, MD, MSCE, Discusses New Era of Dynamic, Trust-Based Health Communication
5
